Canntab Therapeutics Limited Reports Earnings Results for the Second Quarter Ended November 30, 2018
January 29, 2019 at 09:58 pm IST
Canntab Therapeutics Limited announced earnings results for the second quarter ended November 30, 2018. For the second quarter, the company announced total revenue was CAD 32,438 compared to CAD 7,623 a year ago. Net loss was CAD 787,397 compared to CAD 247,328 a year ago. Basic loss per share was CAD 0.03 compared to CAD 0.01 a year ago. For the half year, total revenue was CAD 64,233 compared to CAD 8,306 a year ago. Net loss was CAD 1.234 million compared to CAD 458,928 a year ago. Basic loss per share was CAD 0.05 compared to CAD 0.02 a year ago.